Application of Carrier and Plasticizer to Improve the Dissolution and Bioavailability of Poorly Water-Soluble Baicalein by Hot Melt Extrusion

被引:38
作者
Zhang, Yilan [1 ]
Luo, Rui [1 ]
Chen, Yi [1 ]
Ke, Xue [1 ]
Hu, Danrong [1 ]
Han, Miaomiao [1 ]
机构
[1] China Pharmaceut Univ, Dept Pharmaceut, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China
关键词
baicalein; carrier; high melting point; hot melt extrusion; plasticizer; solid dispersion; SOLID DISPERSIONS; PART I; POLYMERS; ENHANCEMENT; SOLUBILITY;
D O I
10.1208/s12249-013-0071-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to develop a suitable formulation for baicalein (a poorly water-soluble drug exhibiting high melting point) to prepare solid dispersions using hot melt extrusion (HME). Proper carriers and plasticizers were selected by calculating the Hansen solubility parameters, evaluating melting processing condition, and measuring the solubility of obtained melts. The characteristic of solid dispersions prepared by HME was evaluated. The dissolution performance of the extrudates was compared to the pure drug and the physical mixtures. Physicochemical properties of the extrudates were characterized by differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and Fourier transform infrared spectroscopy (FTIR). Relative bioavailability after oral administration in beagle dogs was assessed. As a result, Kollidon VA64 and Eudragit EPO were selected as two carriers; Cremophor RH was used as the plasticizer. The dissolution of all the extrudates was significantly improved. DSC and PXRD results suggested that baicalein in the extrudates was amorphous. FTIR spectroscopy revealed the interaction between drug and polymers. After oral administration, the relative bioavailability of solid dispersions with VA64 and EPO was comparative, about 2.4- and 2.9-fold greater compared to the pure drug, respectively.
引用
收藏
页码:560 / 568
页数:9
相关论文
共 19 条
[1]  
Aharoni SM, 1998, POLYM ADVAN TECHNOL, V9, P169, DOI 10.1002/(SICI)1099-1581(199803)9:3<169::AID-PAT740>3.3.CO
[2]  
2-Q
[3]  
[Anonymous], 2012, Drug Discov Today Technol, V9, pe71, DOI 10.1016/j.ddtec.2011.10.002
[4]   Pharmaceutical applications of hot-melt extrusion: Part I [J].
Crowley, Michael M. ;
Zhang, Feng ;
Repka, Michael A. ;
Thumma, Sridhar ;
Upadhye, Sampada B. ;
Battu, Sunil Kumar ;
McGinity, James W. ;
Martin, Charles .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2007, 33 (09) :909-926
[5]   Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder [J].
Ghosh, Indrajit ;
Snyder, Jennifer ;
Vippagunta, Radha ;
Alvine, Marilyn ;
Vakil, Ronak ;
Tong, Wei-Qin ;
Vippagunta, Sudha .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 419 (1-2) :12-19
[6]   Solubility parameters as predictors of miscibility in solid dispersions [J].
Greenhalgh, DJ ;
Williams, AC ;
Timmins, P ;
York, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (11) :1182-1190
[7]   In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion [J].
He, Haibing ;
Yang, Rui ;
Tang, Xing .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2010, 36 (06) :681-687
[8]   Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: The utility of KinetiSol® Dispersing [J].
Hughey, Justin R. ;
Keen, Justin M. ;
Brough, Chris ;
Saeger, Sophie ;
McGinity, James W. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 419 (1-2) :222-230
[9]   Application of mixtures of polymeric carriers for dissolution enhancement of oxeglitazar using hot-melt extrusion [J].
Kalivoda, Adela ;
Fischbach, Matthias ;
Kleinebudde, Peter .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 439 (1-2) :145-156
[10]   Comparison of metabolic pharmacokineties of baicalin and baicalein in rats [J].
Lai, MY ;
Hsiu, SL ;
Tsai, SY ;
Hou, YC ;
Chao, PDL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (02) :205-209